Chronochemistry in neurodegeneration

Frontiers in Molecular Neuroscience

Volumn 7, Issue MAR, 2014, Pages

  Pastore, Annalisa ^a   Adinolfi, Salvatore ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Alzheimer's disease; Determinism; Disease development; Friedreich's ataxia

Indexed keywords

ACONITATE HYDRATASE; AMYLOID BETA PROTEIN; DOXYCYCLINE; FRATAXIN; IRON SULFUR CLUSTER PROTEIN; PEPTIDES AND PROTEINS; PROTEIN KINASE FES; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; CHEMISTRY; CHRONOCHEMISTRY; FRIEDREICH ATAXIA; GENE EXPRESSION; HUMAN; IRON PRECIPITATION; LONG TERM DEPRESSION; MUTANT; NERVE DEGENERATION; NONHUMAN; OXIDATIVE STRESS; PRECIPITATION; PROTEIN AGGREGATION; REVIEW; SYNAPSE;

EID: 84897377959     PISSN: 16625099     EISSN: None     Source Type: Journal    
DOI: 10.3389/fnmol.2014.00020     Document Type: Review

References (50)

1. Adinolfi, S., Iannuzzi, C., Prischi, F., Pastore, C., Iametti, S., Martin, S., et al. (2009). Bacterial frataxin CyaY is the gatekeeper of iron-sulphur cluster formation catalyzed by IscS. Nat. Struct. Mol. Biol. 4, 390-396. doi: 10.1038/nsmb.1579
2. Alzheimer, A. (1907). On a peculiar disease of the cerebral cortex. Allgemeine Z. Psychiatr. Psychish Gerichtlich Med. 64, 146-148.
3. Anderson, P. R., Kirby, K., Hiliker, A. J., and Phillips, J. P. (2005). RNAi-mediated suppression of the mitochondrial iron chaperone, frataxin, in Drosophila. Hum. Mol. Genet. 15, 3397-3405. doi: 10.1093/hmg/ddi367
4. Asimov, I. (1948). "The endochronic properties of resublimated thiotimoline," in Astounding Science Fiction, ed. J. W. Campbell Jr. (New York: Street & Smith Publ., Inc.), 120-126.
5. Babcock, M., de Silva, D., Oaks, R., Davis-Kaplan, S., Jiralerspong, S., Mon-termini, L., et al. (1997). Regulation of mitochondrial iron accumulation by Yfh1p a putative homolog of Frataxin. Science 276, 1709-1712. doi: 10.1126/science.276.5319.1709
6. Bridwell-Rabb, J., Iannuzzi, C., Pastore, A., and Barondeau, D. (2012). Effector role reversal during evolution: the case of frataxin in Fe-S cluster biosynthesis. Biochemistry 27, 2506-2514. doi: 10.1021/bi201628j
7. Brion, J. P., Couck, A. M., Passareiro, E., and Flament-Durand, J. (1985). Neurofibril-lary tangles of Alzheimer's disease: an immunohistochemical study. J. Submicrosc. Cytol. 17, 89-96.
8. Campuzano, V., Montermini, L., Lutz, Y., Cova, L., Hindelang, C., Jiralerspong, S., et al. (1997). Frataxin is reduced in Friedreich's ataxia patients and is associated with mitochondrial membrane. Hum. Mol. Genet. 6, 1771-1780. doi: 10.1093/hmg/6.11.1771
9. Campuzano, V., Montermini, L., Moltò, M. D., Pianese, L., Cossée, M., Caval-canti, F., et al. (1996). Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science 271, 1423-1427. doi: 10.1126/science.271.5254.1423
10. Capstick, D. S., Jomaa, A., Hanke, C., Ortega, J., and Elliot, M. A. (2011). Dual amyloid domains promote differential functioning of the chaplin proteins during Streptomyces aerial morphogenesis. Proc. Natl. Acad. Sci. U.S.A. 108, 9821-9826. doi: 10.1073/pnas.1018715108
11. Christensen, K., Doblhammer, G., Rau, R., and Vaupel, J. W. (2009). Ageing populations: the challenges ahead. Lancet 374, 1196-1208. doi: 10.1016/S0140-6736(09)61460-4
12. Cossée, M., Puccio, H., Gansmuller, A., Koutnikova, H., Dierich, A., LeMeur, M., et al. (2000). Inactivation of the Friedreich ataxia mouse gene leads to early embryonic lethality without iron accumulation. Hum. Mol. Genet. 9, 1219-1226. doi: 10.1093/hmg/9.8.1219
13. Eichner, T., and Radford, S. E. (2011). A diversity of assembly mechanisms of a generic amyloid fold. Mol. Cell 43, 8-18. doi: 10.1016/j.molcel.2011.05.012
14. Gibson, T. J., Koonin, E. V., Musco, G., Pastore, A., and Bork, P. (1996). Friedre-ich's ataxin protein: phylogenetic evidence for mitochondrial dysfunction. Trends Neurosci. 19, 465-468. doi: 10.1016/S0166-2236(96)20054-2
15. Glenner, G. G., and Wong, C. W. (1984). Alzheimer's disease and Down's syndrome: sharing of a unique cerebrovascular amyloid fibril protein. Biochem. Biophys. Res. Commun. 122, 1131-1135. doi: 10.1016/0006-291X(84)91209-9
16. Hardy, J., and Allsop, D. (1991). Amyloid deposition as the central event in the aetiology of alzheimer's disease. Trends Pharmacol. Sci. 12, 383-388. doi: 10.1016/0165-6147(91)90609-V
17. Hardy, J., and Selkoe, D. J. (2002). The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297, 353-356. doi: 10.1126/science.1072994
18. Isaya, G., Adamec, J., Rusnak, F., Owen, W. G., Naylor, S., and Benson, L. (2000). Frataxin is an iron storage protein. Am. J. Hum. Genet. 67, 549-562.
19. Kang, J., Lemaire, H.-G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K.-M., et al. (1987). The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 325, 733-736. doi: 10.1038/ 325733a0
20. Kumanovics, A., Chen, O. S., Li, L., Bagley, D., Adkins, E. M., Lin, H., et al. (2008). Identification of FRA1 and FRA2 as genes involved in regulating the yeast iron regulon in response to decreased mitochondrial iron-sulphur synthesis. J. Biol. Chem. 283, 10276-10286. doi: 10.1074/jbc.M801160200
21. Kuo, Y.-M., Emmerling, M. R., Vigo-Pelfrey, C., Kasunic, T. C., Kirkpatrick, J. B., Murdoch, G. H., et al. (1996). Water-soluble Aβ (N-40, N-42) oligomers in normal and Alzheimer disease brains. J. Biol. Chem. 271, 4077-4081. doi: 10.1074/jbc.271.8.4077
22. Lambert, M. P., Barlow, A. K., Chromy, B. A., Edwards, C., Freed, R., Iosatos, M., et al. (1998). Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proc. Natl. Acad. Sci. U.S.A. 95, 6448-6453. doi: 10.1073/pnas.95.11.6448
23. Li, H., Gakh, O., Smith, D. Y., and Isaya, G. (2009a). Oligomeric yeast frataxin drives assembly of core machinery for mitochondrial iron-sulphur cluster synthesis. J. Biol. Chem. 14, 21971-21980. doi: 10.1074/jbc.M109.011197
24. Li, S., Hong, S., Shepardson, N. E., Walsh, D. M., Shankar, G. M., and Selkoe, D. (2009b). Soluble oligomers of amyloid β protein facilitate hippocampal long-term depression by disrupting neuronal glutamate uptake. Neuron 62, 788-801. doi: 10.1016/j.neuron.2009.05.012
25. Llorens, J. V., Navarro, J. A., Martinez-Sebastian, M. J., Baylies, M. K., Schneuwly, S., Botella, J. A., et al. (2007). Causative role of oxidative stress in a Drosophila model of Friedreich ataxia. FASEB J. 21, 333-344. doi: 10.1096/fj.05-5709com
26. Lue, L. F., Kuo, Y. M., Roher, A. E., Brachova, L., Shen, Y., Sue, L., et al. (1999). Soluble amyloid β peptide concentration as a predictor of synaptic change in Alzheimer's disease. Am. J. Pathol. 155, 853-862. doi: 10.1016/S0002-9440(10)65184-X
27. Luheshi, L. M., Crowther, D. C., and Dobson, C. M. (2008). Protein misfolding and disease: from the test tube to the organism. Curr. Opin. Chem. Biol. 12, 25-31. doi: 10.1016/j.cbpa.2008.02.011
28. Ma, B., and Nussinov, R. (2012). Selective molecular recognition in amyloid growth and transmission and cross-species barriers. J. Mol. Biol. 421, 172-184. doi: 10.1016/j.jmb.2011.11.023
29. Maji, S. K., Perrin, M. H., Sawaya, M. R., Jessberger, S., Vadodaria, K., Rissman, R. A., et al. (2009). Functional amyloids as natural storage of peptide hormones in pituitary secretory granules. Science 325, 328-332. doi: 10.1126/science.1173155
30. Marshall, K. E., and Serpell, L. C. (2009). Structural integrity of beta-sheet assembly. Biochem. Soc. Trans. 37, 671-676. doi: 10.1042/BST0370671
31. Martelli, A., Napierala, M., and Puccio, H. (2012). Understanding the genetic and molecular pathogenesis of Friedreich's ataxia through animal and cellular models. Dis. Model. Mech. 5, 165-176. doi: 10.1242/dmm.008706
32. Masters, C. L., and Selkoe, D. J. (2012). Biochemistry of amyloid β-protein and amyloid deposits in Alzheimer disease. Cold Spring Harb. Perspect. Med. 2:a006262. doi: 10.1101/cshperspect.a006262
33. McLean, C. A., Cherny, R. A., Fraser, F. W., Fuller, S. J., Smith, M. J., Beyreuther, K., et al. (1999). Soluble pool of Aβ amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease. Ann. Neu-rol. 46, 860-866. doi: 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0. CO;2-M
34. Moreno-Cermeno, A., Obis, E., Belli, G., Cabiscol, E., Ro, J., and Tamarit, J. (2010). Frataxin depletion in yeast triggers up-regulation of iron transport systems before affecting iron-sulphur enzyme activities. J. Biol. Chem. 285, 41653-41664. doi: 10.1074/jbc.M110.149443
35. Mudher, A., and Lovestone, S. (2002). Alzheimer's disease-do tauists and baptists finally shake hands? Trends Neurosci. 25, 22-26. doi:10.1016/S0166-2236(00)02031-2
36. Muhlenkhoff, U., Richhardt, N., Ristow, M., Kispal, G., and Lill, R. (2002). The yeast frataxin homolog Yfh1p plays a specific role in the maturation of cellular Fe/S proteins. Hum. Mol. Genet. 11, 2025-2036. doi: 10.1093/hmg/11. 17.2025
37. Pastore, A., and Puccio, H. (2013). Frataxin: a protein in search for a function. J. Neurochem. 126, 43-52. doi: 10.1111/jnc.12220
38. Prischi, F., Konarev, P. V., Iannuzzi, C., Pastore, C., Adinolfi, S., Martin, S. R., et al. (2010). Structural bases for the interaction of frataxin with the central components of iron-sulphur cluster assembly. Nat. Commun. 1, 95. doi: 10.1038/ncomms1097
39. Puccio, H., Simon, D., Cossée, M., Criqui-Filipe, P., Tiziano, F., Melki, J., et al. (2001). Mouse model for Friedreich ataxia exhibit cardiomyopathy, sensory nerve defect and Fe-S enzyme deficiency followed by intramitochondrial iron deposits. Nat. Genet. 27, 181-186. doi: 10.1038/84818
40. Rodriguez-Manzaneque, M. T., Tamarit, J., Belli, G., Ros, J., and Herrero, E. (2002). Grx5 is a mitochondrial glutaredoxin required for the activity of iron/sulphur enzymes. Mol. Biol. Cell 13, 1109-1121. doi: 10.1091/mbc.01-10-0517
41. Roting, A., de Lonlay, P., Chretien, D., Foury, F., Koenig, M., Sidi, D., et al. (1997). Aconitase and mitochondrial iron-sulphur protein deficiency in Friedreich ataxia. Nat. Genet. 17, 215-217. doi: 10.1038/ng1097-215
42. Sanchez-Casis, G., Cote, M., and Barbeau, A. (1977). Pathology of the heart in Friedreich's ataxia: review of the literature and report of one case. Can. J. Neurol. Sci. 3, 349-354.
43. Selkoe, J. (2011). Alzheimer's disease. Cold Spring Harb. Perspect. Biol. 3:a004457. doi: 10.1101/cshperspect.a004457
44. Serrano-Pozo, A., Frosch, M. P., Masliah, E., and Hyman, B. T. (2011). Neu-ropathological alterations in Alzheimer disease. Cold Spring Harb. Perspect. Med. 1:a006189. doi: 10.1101/cshperspect.a006189
45. Shankar, G. M., Li, S., Mehta, T. H., Garcia-Munoz, A., Shepardson, N. E., Smith, I., et al. (2008). Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nat. Med. 14, 837-842. doi: 10.1038/nm1782
46. Stine, W. B. Jr., Dahlgren, K. N., Krafft, G. A., and LaDu, M. J. (2003). In vitro characterization of conditions for amyloid-β peptide oligomerization and fibrillogenesis. J. Biol. Chem. 278, 11612-11622. doi: 10.1074/jbc.M210207200
47. Tsai, C. L., and Barondeau, D. (2010). Human frataxin is an allosteric switch that activates the Fe-S cluster biosynthetic complex. Biochemistry 49, 9132-9139. doi: 10.1021/bi1013062
48. Wang, J., Dickson, D. W., Trojanowski, J. Q., and Lee, V. M. (1999). The levels of soluble versus insoluble brain Aβ distinguish Alzheimer's disease from normal and pathologic aging. Exp. Neurol. 158, 328-337. doi: 10.1006/exnr.1999.7085
49. Wang, Q., Walsh, D. M., Rowan, M. J., Selkoe, D. J., and Anwyl, R. (2004). Block of long-term potentiation by naturally secreted and synthetic amyloid b-peptide in hippocampal slices is mediated via activation of the kinases c-Jun N-terminal kinase, cyclin-dependent kinase 5, and p38 mitogenactivated protein kinase as well as metabotropic glutamate receptor type 5. J. Neurosci. 24, 3370-3378. doi: 10.1523/JNEUROSCI.1633-03.2004
50. Wang, X., Hammer, N. D., and Chapman, M. R. (2008). The molecular basis of functional bacterial amyloid polymerization and nucleation. J. Biol. Chem. 283, 21530-21539. doi: 10.1074/jbc.M800466200